Timothy Cloughesy, MD

Timothy Cloughesy, MD

Neurology Los Angeles, CA

Professor of Neuology/Director, UCLA NeuroOncology Program


Office Address

  • 300 UCLA Medical Plaza
    Suite B200
    Los Angeles, CA 90095
    Phone: (310) 825-5321
    Fax: (310) 825-0644

Timothy Cloughesy, MD

Neurology Los Angeles, CA

Professor of Neuology/Director, UCLA NeuroOncology Program

Clinical Specialties & Interests

  • Neurology: Neurooncology

Education & Training

  • UCLA Medical CenterUCLA Medical Center
  • Maricopa Medical CenterMaricopa Medical Center
  • Tulane University School of MedicineTulane University School of Medicine

Certifications & Licensure

  • CA State Medical LicenseCA State Medical License1988 - 2016
  • American Board of Psychiatry and NeurologyNeurology

    Awards, Honors, & Recognition

    • America's Top DoctorsCastle Connolly, 2014, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002
    • Top Doctors:LA AreaCastle Connolly, 2013
    • America's Top Doctors for CancerCastle Connolly, 2013, 2012, 2011, 2010, 2009, 2008, 2007, 2006, 2005

    Clinical Trials

    Publications & Presentations

    PubMed

    Grant Support

    • UCLA IRB 08-09-042: Phase I Trial Of Aflibercept (Vegf Trap) With Radiation TheNational Center For Research Resources
      2010 - 2010
    • UCLA IRB # 06-04-104 "A Phase I/II, Dual-Center, Open-Label Trial Of The SAFENational Center For Research Resources
      2009 - 2010
    • Phase II Single Arm Trial Of VEGF TRAP In Patients With Recurrent Temozolomide-National Center For Research Resources
      2009 - 2009
    • Clinical Trial: A Phase II Trial Of Poly-Iclc In Patients With Recurrent AnaplasNational Center For Research Resources
      2008 - 2008
    • Recurrent Temozolomide-Resistant Malignant GliomasNational Center For Research Resources
      2008 - 2008
    • "A Phase I/II Studies Of BAY 43-9006 (SORAFENIB) In CombinNational Center For Research Resources
      2008 - 2008
    • UCLA IRB #05-12-061 "A Phase I Study Of Vorinostat (Suberoylanilide HydroxamiNational Center For Research Resources
      2007 - 2009
    • UCLA IRB (PENDING) "A Phase I/II Studies Of BAY 43-9006 (SORAFENIB) In CombinNational Center For Research Resources
      2007 - 2009
    • Phase I/II Study Of OSI-774 (ERLOTINIB) And CCI-779 (TEMSIROLIMUS) In PatientNational Center For Research Resources
      2007 - 2010
    • A Biomarker And Phase II Study Of GW 572016 In Recurrent Malignant Glioma (NaNational Center For Research Resources
      2007 - 2008
    • UCLA IRB # 06-04-016 "Phase II Trial Of Bevacizumab In Combination With TemozNational Center For Research Resources
      2007 - 2010
    • Consortium Therapeutic Studies Of Primary Central Nervous System MalignanciesNational Cancer Institute
      2007 - 2008
    • A Multicenter, Open-Label, Randomized, Uncontrolled, Phase IIA Trial In SubjeNational Center For Research Resources
      2006 - 2006
    • Phase II Trial Of EMD 121974 For Recurrent Glioblastoma: A Clinical Trial WitNational Center For Research Resources
      2006 - 2007
    • A Phase I/II Trial Of OSI-774 In Patients With Recurrent Malignant Gliomas AnNational Center For Research Resources
      2005 - 2006
    • Consortium Therapeutic Studies Of Primary Central Nervi*National Cancer Institute
      2005 - 2006
    • A Modified Phase I/II Trial Of Rapamycin In Patients With Malignant GliomasNational Center For Research Resources
      2005 - 2006
    • Phase I-II Trial Of STI-571 (Nsc 716051) In Patients With Recurrent MalignantNational Center For Research Resources
      2005 - 2005
    • Phase II Trial Of Poly-Iclc For Glioblastoma [Nabtc 01-05]National Center For Research Resources
      2005 - 2005
    • A Phase II Trial Of STI-571 ( NSC 716051) In Patients With Recurrent MeningioNational Center For Research Resources
      2005 - 2006
    • ZD1839 For Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or GLINational Center For Research Resources
      2005 - 2006
    • A Phase II Trial Of Poly-Iclc In Patients With Recurrent Anaplastic Glioma NNational Center For Research Resources
      2005 - 2007
    • Phase I/II Of R115777 In Patients With Recurrent Malignant GliomasNational Center For Research Resources
      2005 - 2005
    • Consortium Therapeutic Studies Of Primary Central Nervi*National Center For Research Resources
      2005 - 2008
    • Quantified Gene Expression Improves PrognosisNational Center For Research Resources
      2004 - 2004
    • Phase II Evaluation Of Fenretinide (Nsc 374551) As A SNational Center For Research Resources
      2004 - 2004
    • Phase I/II Trial Of OSI-774 In Patients With RecurrentNational Center For Research Resources
      2004 - 2004
    • ZD1839 For Treatment Of Recurrent Or Progressive Malignant Astrocytoma Or Gli...National Center For Research Resources
      2004 - 2004
    • Phase I/II Trial Of CCI-779 In Patients With Malignant Gliomas (Nabtc 01-01)National Center For Research Resources
      2004 - 2004
    • Phase I/II Of R115777 For Recurrent Malignant GliomasNational Center For Research Resources
      2004 - 2004
    • Consortium Therapeutic Studies Of CNS MalignanciesNational Cancer Institute
      2004 - 2004
    • Modified Phase I/II Trial Of Rapamycin In Patients WitNational Center For Research Resources
      2004 - 2004
    • Phase I/II Trial Of Ironstecan In Patients With GliomaNational Center For Research Resources
      2001 - 2001
    • Phase 2 Trial Of Thymidine/Carboplatin Therapy Of GliomaNational Center For Research Resources
      2001 - 2001
    • Gene Expression Prognosis &Trtmt Response Stratification In PATS W/ GliomaNational Center For Research Resources
      1999 - 2002
    • Quantify Gene Expression: Prognosis &Therapy Response Stratification In GliomaNational Center For Research Resources
      1998 - 1998

    Insurance Accepted

    • Aetna Choice POS II
    • Aetna HMO
    • BCBS Blue Card PPO
    • BCBS California CaliforniaCare HMO
    • BCBS California PPO
    • CIGNA HMO
    • CIGNA Open Access
    • CIGNA PPO
    • First Health PPO
    • Great West PPO
    • Health Net California Large Group PPO
    • Multiplan PHCS PPO
    • Multiplan PHCS PPO - Kaiser
    • Multiplan PPO
    • Pacificare HMO
    • United Healthcare - Direct Choice Plus POS
    • United Healthcare - Direct Options PPO

    Links

    • The full profile is locked and available to verified physicians only.
      Join over 60% of U.S. physicians already on Doximity and get access to this and over 700,000 physician CVs. Find your physician profile

    Physicians, view Dr. Cloughesy's full Doximity profile to:

    • Trade HIPAA-secure messages
    • Send and receive online faxes
    • Refer a patient
    • See their complete CV